about
Prevalence of canine heartworm (Dirofilaria immitis) disease in dogs of central PortugalAssessment of parasitological findings in heartworm-infected beagles treated with Advantage Multi® for dogs (10% imidacloprid + 2.5% moxidectin) and doxycycline.Establishment of macrocyclic lactone resistant Dirofilaria immitis isolates in experimentally infected laboratory dogs.Dirofilaria immitis and Wolbachia pipientis: a thorough investigation of the symbiosis responsible for canine heartworm disease.Canine vector-borne infections in MauritiusA histochemical study of the Nras/let-60 activity in filarial nematodes.Heartworms, macrocyclic lactones, and the specter of resistance to prevention in the United States.First analysis of the secretome of the canine heartworm, Dirofilaria immitis.Identification of Dirofilaria immitis miRNA using illumina deep sequencing.Successful treatment of Brugia pahangi in naturally infected cats with ivermectin.Progress and challenges in the discovery of macrofilaricidal drugs.Treatment of MDR1 mutant dogs with macrocyclic lactonesFalse negative antigen tests in dogs infected with heartworm and placed on macrocyclic lactone preventives.Canine ocular onchocerciasis: a retrospective review of the diagnosis, treatment, and outcome of 16 cases in New Mexico (2011-2015).Considerations for using minocycline vs doxycycline for treatment of canine heartworm disease.Clinical benefits of incorporating doxycycline into a canine heartworm treatment protocol.Can P-glycoprotein and β-tubulin polymorphisms be used as genetic markers of resistance in Dirofilaria immitis from Rio de Janeiro, Brazil?
P2860
Q24604747-0F102A8D-5C43-4918-BEA3-3207AEDBC2B3Q33706247-BC4528CC-F55B-410A-8E19-7301D1D015F4Q34492057-E39216D6-28AC-4305-A81E-F5C582A506FBQ34632373-84DC0954-182A-46ED-B9AD-4B5254E8805EQ35206485-72F60CFB-8FBE-4800-8E6D-B29E589B7D40Q35825354-7CF04044-2892-474A-9992-3C7873C8A4E2Q36123129-FADB4A91-3D49-4C49-BA6E-A0A9C7729546Q36226375-3F7F469D-CB48-437C-BDF6-DD5999197609Q36688525-972E20C3-CA5B-4623-8FF0-D26F8C02F0DBQ37563248-01A068EA-13BA-4B65-9864-B4CBAD65ACFEQ37912232-A2CDD6DE-137A-4DEE-A9A3-47D2216BFFF0Q37951034-E3A6FDE0-2A36-48CA-BBDD-FAC8419F84BEQ38342797-C94C7EEA-C8A0-4604-8E7E-E4D34C9A5D48Q38953717-60026EA5-3F2C-44AC-B678-117E9BFF8EE8Q44877114-0E35AEA3-CB3A-4EE7-AA5F-20D5890C9C0CQ45502555-A47B5C08-B770-421D-B5A1-931458403E4BQ52687923-94008138-1BDE-46F3-AB34-A974B2C61708
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Heartworm and Wolbachia: therapeutic implications.
@en
Heartworm and Wolbachia: therapeutic implications.
@nl
type
label
Heartworm and Wolbachia: therapeutic implications.
@en
Heartworm and Wolbachia: therapeutic implications.
@nl
prefLabel
Heartworm and Wolbachia: therapeutic implications.
@en
Heartworm and Wolbachia: therapeutic implications.
@nl
P2093
P1476
Heartworm and Wolbachia: therapeutic implications.
@en
P2093
A M Mansour
J Guerrero
J W McCall
M T Dzimianski
N Supakorndej
P Supakorndej
S D McCall
P304
P356
10.1016/J.VETPAR.2008.09.008
P577
2008-09-07T00:00:00Z